FDA panel to review Pfizer and Moderna vaccines for children aged six month to 4 years on June 15
May 24, 2022 at 09:58 AM EDT
The Food and Drug Administration said Monday an advisory panel would meet June 15 to discuss use of the vaccines developed by Pfizer and German partner BioNTech, as well as the one developed by Moderna, in children aged 6 months to four years old.